October 21, 2013
CTI Clinical Trial and Consulting Services (CTI)’s newly expanded department, S2 Health Economics Outcomes Research (S2 HECOR), announces the launch of S2 Hospital Insights, an innovative web-based tool that provides a look at definitive hospital reimbursement data. With this exclusive information, pharmaceutical, biotechnology, and medical device companies, along with healthcare systems and insurers, can quickly and easily identify the amount of reimbursement they can expect from specific procedures.
Candace Gunnarsson, Ed.D., Vice President S2 HECOR, explains, “In today’s complex healthcare delivery environment, providers need to know the amount of reimbursement they can reasonably anticipate in order to develop operational strategies, identify trends, and plan budgets. S2 Hospital Insights makes this possible. Our team is extremely knowledgeable about hospital databases, and we can perform analytics or provide consulting services in conjunction with the data from this tool. ” MedAssets Health Data Analytics, a solution offered by MedAssets, a provider of technology-enabled products and services, is the data source for S2 Hospital Insights. MedAssets aggregates data from more than 400 hospitals across 42 states, covering inpatient and outpatient stays from 2008 to 2012. This rich data source allows researchers to perform sophisticated analyses such as economic evaluations and comparative effectiveness research.
“We are delighted to collaborate with MedAssets to offer this exclusive and robust data to our clients as they expand their health economics outcomes research initiatives,” says Dr. Gunnarsson.
The S2 Hospital Insights search tool is accessed through http://s2stats.com/tools/insights, which uses common diagnoses and procedures based on the International Classification of Diseases, 9th Revision (ICD-9) and Diagnosis-Related Group descriptions for hospital reimbursement information by payer type. It is based on more than 4.8 million inpatient stays in 2011.
With a simple click, users can immediately see the differences among reimbursements from commercial payers, Medicare, and Medicaid for various conditions. For example, a diagnosis of chronic hepatitis C. without hepatic coma shows mean reimbursements of $75,673 for commercial insurers, $30,523 for Medicare, and $18,240 for Medicaid. In addition to the mean, S2 Hospital Insights provides the median, standard deviation, and additional data, accompanied by a simple bar chart.